Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Charles Gross

1934 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Insider Trades
  • Management
  • News

Kingsoft Cloud Announced Share Purchase by Vice Chairman and Chief Executive Office

By Charles Gross
June 9, 8:55 AM
Kingsoft Cloud Holdings Limited (“we,” “Kingsoft Cloud” or the “Company”) (NASDAQ:KC), a leading independent cloud service provider in China, today announced that the board (the

KC

Read More
1 minute read
  • News

AstraZeneca Announced Danicopan As Add-on To Ultomiris Or Soliris Improved Haemoglobin Levels And Maintained Disease Control In Patients With PNH Experiencing Signs Of Clinically Significant Extravascular Haemolysis

By Charles Gross
June 9, 4:51 AM
Results from ALPHA Phase III trial demonstrated statistically significant increase compared to placebo in mean haemoglobin from baseline to week 12. All key secondary endpoints met statistical superiority, showing

AZN

Read More
1 minute read
  • News
  • Offerings

GE HealthCare Technologies Late Wednesday Priced Secondary Offering of 25M Shares @$78/Share

By Charles Gross
June 8, 5:18 AM
GE HealthCare Technologies Inc. (NASDAQ:GEHC) (the "Company" or "GE HealthCare") announced today the pricing of the previously announced secondary underwritten public offering (the

GEHC

Read More
1 minute read
  • News
  • Offerings

Sterling Late Wednesday Priced 8M Share Secondary Public Offering By Selling Shareholders @$12.25/Share

By Charles Gross
June 8, 5:16 AM
Sterling Check Corp. (NASDAQ:STER) ("Sterling"), a leading global provider of technology-enabled background and identity verification services, today announced the pricing of an underwritten secondary public

STER

Read More
1 minute read
  • News
  • Offerings

Skyward Specialty Late Wednesday Priced 3.85M Share Secondary Offering of Its Common Stock @$23/Share

By Charles Gross
June 8, 5:15 AM
Skyward Specialty Insurance Group, Inc.TM (NASDAQ:SKWD) ("Skyward Specialty" or the "Company"), a leader in the specialty property and casualty ("P&C") market, today announced the

SKWD

Read More
1 minute read
  • News
  • Offerings

Mobileye Priced 38.5M Share Secondary Offering of Shares of Class A Common Stock @$42/Share

By Charles Gross
June 8, 5:13 AM
Mobileye Global Inc. (NASDAQ:MBLY) ("Mobileye") today announced the pricing of a previously announced underwritten secondary public offering of 38,500,000 shares of Mobileye's Class A common stock by Intel

MBLY

Read More
1 minute read
  • News
  • Offerings

Blue Bird Earlier Priced 4.5M Share Secondary Public Offering By Selling Shareholders @$20/Share

By Charles Gross
June 8, 5:11 AM
Blue Bird Corporation ("Blue Bird" or the "Company") (NASDAQ:BLBD), a leader in electric and low-emission school buses, announced today the pricing of an underwritten secondary public offering by

BLBD

Read More
1 minute read
  • News
  • Offerings

Akoya Biosciences Earlier Priced 8.7< Share Public Offering of Common Stock @$5/Share

By Charles Gross
June 8, 5:09 AM
Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced the pricing of its public offering of 8,700,000 shares of common stock (the "Offering") at a public

AKYA

Read More
1 minute read
  • Guidance
  • News

Sandoz Announced At Capital Markets Day Plans For Growth And Success As A Standalone Company, Following The Proposed 100% Spin-off From Novartis

By Charles Gross
June 8, 5:05 AM
Sandoz today hosts the first of two Capital Markets Days (CMDs) for investors, in New York City, to set out its plans for growth and success as a standalone company, following the proposed 100% spin-off from

NVS

Read More
1 minute read
  • News
  • Offerings

Cogent Biosciences Priced Upsized 12.5M Share Public Offering of Shares of Common Stock @$12/Share

By Charles Gross
June 7, 5:35 AM
Cogent Biosciences, Inc. (NASDAQ:COGT) announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a public offering price

COGT

Posts pagination

Previous 1 … 24 25 26 … 194 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service